Announcements Trials

Browse Landscape

Status

Completed 5 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7 Tumor-Agnostic 4 Gynecologic 3 Lymphoid 2 Head & Neck 2 Genitourinary 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 NET 1 Endocrine 1 CNS 1 Breast 1

Conditions

Small Cell Lung Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 182 pembrolizumab 157 Pemetrexed 132 Cisplatin 98 Drug Therapy 68 Paclitaxel 61 osimertinib 55 Nivolumab 50 Magnetic Resonance Spectroscopy 50 Specimen Handling 49 durvalumab 48 Radiotherapy 48 Docetaxel 44 atezolizumab 43 Etoposide 40 Bevacizumab 39 tislelizumab 33 Blood Specimen Collection 33 Radiosurgery 31 Gemcitabine 29 130-nm albumin-bound paclitaxel 28 Immunotherapy 26 Immune Checkpoint Inhibitors 24 cemiplimab 23 Injections 22 aflutinib 20 Cetuximab 19 Biopsy 18 Platinum Compounds 17 Surgical Procedures, Operative 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Data Collection × Thoracic × Clear all

NCT02622581 2025-02-18

CRISP

AIO-Studien-gGmbH

12,400 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡